The reporting checklist of health technology assessment (HTA) was a tool developed by the International Network of Agencies for Health Technology Assessment (INAHTA) to be used to guide the reporting of HTA. Experiential evidence showed that the tool was effective to improve the reporting quality of HTA and also could be used as a reference in performing HTA and translating the research evidence into decision-making. This paper introduced the background, developing process and main contents of the checklist, so as to improve the reporting quality of HTA in China.
ObjectiveTo investigate diagnosis, gene detection, and treatment principle of medullary thyroid carcinoma.Method The relevant literatures and guidelines about diagnosis and treatment of medullary thyroid carcinoma were summarized and analyzed retrospectively. Resultsmedullary thyroid carcinoma was given priority to surgical treatment. hereditary medullary cancer could be prophylactic thyroidectomy by the RET gene test results. advanced progressive medullary thyroid carcinoma, could be treated by palliative surgery, external radiotherapy, or systemic treatment with the tyrosine kinase inhibitor. ConclusionsPrognosis of medullary thyroid carcinoma is worse, and occurrence of early metastasis is easy. so the first operation should be thoroughgoing. and the operation timing of prophylactic total thyroidectomy for hereditary medullary cancer could be determined by the results of RET gene detection to achieving early cure.
ObjectiveTo evaluate whether strategic parathyroid autotransplantation can decrease the incidence of hypoparathyroidism after central lymph node re-dissection in patients with papillary thyroid carcinoma. MethodsData were retrospectively collected from the patients with papillary thyroid carcinoma, who had undergone unilateral or bilateral central lymph node re-dissection in the Department of Thyroid Surgery, West China Hospital of Sichuan University between January 2009 and October 2015. The patients were divided into transplantation group and non-transplantation group according to the history of strategic parathyroid autotransplantation in the primary surgery. Data concerning patient demographics (age, sex, comorbidities, the leval of Ca2+ and parathyroid hormone, previous surgical manners and complications before reoperation), surgical manners of reoperation, and postoperative factors (laboratory examination and postoperative complications) were collected. ResultsA total of 74 patients, 35 in the transplantation group and 39 in the non-transplantation group, were included in the study. Significantly higher levels of Ca2+ and parathyroid hormone were observed in the transplantation group than in the non-transplantation group on one day after surgery (P < 0.05). Recurrent laryngeal nerve injury newly occurred in 2 patients in the transplantation group and 5 patients in the non-transplantation group, respectively (5.7% vs. 12.8%, P > 0.05). Transient hypoparathyroidism was documented in 4 patients in the transplantation group and in 12 patients in the non-transplantation group. Permanent hypoparathyroidism was documented in 1 patient in the transplantation group and in 4 patients in the non-transplantation group. The incidence of hypoparathyroidism was significantly lower in the transplantation group compared with the non-transplantation group (5 vs. 16, P < 0.05). The mean number of central lymph node identified pathologically was significantly more in the transplantation group (2.1±1.3 vs. 1.4±0.7, P < 0.05). ConclusionStrategic parathyroid autotransplantation can effectively decrease the incidence of hyperparathyroidism after central lymph node re-dissection in patients with papillary thyroid carcinoma, which greatly improves the surgical safety and thoroughness.